Search - tctmd.com

Displaying 221 - 240 of 350

Sort: Relevancy | Date

Presentation TCT 2015

Debate: Are We Really Ready for Phase III Trials? For Limb Ischemia There Are Knowns and Unknowns!

Presenter: Francisco Fdez-Aviles, Timothy D. Henry, Amit Patel

October 15, 2015

Presentation TCT 2015

In Patients With End-stage Coronary Artery Disease With Ischemia and Scar, Which Cell Type Will Work Best? No Cell Works. Genes are the Answer.

Presenter: Nabil Dib, Philippe Menasché, Marc S. Penn

October 15, 2015

Presentation TCT 2015

In Patients With End-stage Coronary Artery Disease With Ischemia and Scar, Which Cell Type Will Work Best? Cardiac Progenitor Cells Are the Only One!

Presenter: Nabil Dib, Philippe Menasché, Timothy D. Henry

October 15, 2015

Presentation TCT 2015

In Patients With End-stage Coronary Artery Disease With Ischemia and Scar, Which Cell Type Will Work Best? Combination of Cells for Additive Effects: This Is the Key!

Presenter: Nabil Dib, Philippe Menasché, Jay H Traverse

October 15, 2015

Presentation TCT 2015

In Patients With End-stage Coronary Artery Disease With Ischemia and Scar, Which Cell Type Will Work Best? Cardiopoietic Commitment Is the Key!

Presenter: Nabil Dib, Philippe Menasché, Amit Patel

October 15, 2015

Presentation TCT 2015

Coronary CT Imaging: Ischemia vs Anatomy

Presenter: Hasan Jilaihawi, Christopher K. Zarins, James K. Min

October 14, 2015

Presentation TCT 2015

Case Introduction: A Complex Diabetic Patient With Heart Failure, Ischemia, and Mitral Regurgitation

Presenter: John D. Puskas

October 14, 2015

Presentation TCT 2015

Stable CAD With Substantial Ischemia and No-to-Mild Symptoms: Initial Revascularization vs Medical Therapy

Presenter: William A. Gray, Gregg W. Stone, D. Christopher Metzger, Sripal Bangalore

October 14, 2015

Presentation TCT 2015

Advanced CLI BTK Intervention: Two Cases From a Master Level Operator

Presenter: J. A. Mustapha, Craig M. Walker, Andrej Schmidt

October 11, 2015

Presentation TCT 2015

Approaching the Critical Limb Ischemia Endovascular Procedure: Planning Access, Tools, and Goals

Presenter: J. A. Mustapha, Craig M. Walker

October 11, 2015

Presentation TCT 2015

To Angiosome or Not to Angiosome? That Is the Question

Presenter: J. A. Mustapha, Craig M. Walker, Osamu Iida

October 11, 2015

Presentation TCT 2015

Debate: Should Most Patients With Stable Ischemic Heart Disease, Moderate or Greater Ischemia, and Controllable Symptoms Undergo Revascularization? Yes, an Evidence-Based Position!

Presenter: Kevin J. Beatt, Craig R. Smith, Gregg W. Stone

October 11, 2015

Presentation TCT 2015

What the Device Approval Trials Will Tell Us About the Endovascular Approach to CLI and What They Wont

Presenter: J. A. Mustapha, Craig M. Walker, Gary M. Ansel

October 11, 2015

Presentation TCT 2015

Debate: Should Most Patients With Stable Ischemic Heart Disease, Moderate or Greater Ischemia, and Controllable Symptoms Undergo Revascularization? The Data Says Not as a First-Line Therapy!

Presenter: Kevin J. Beatt, Craig R. Smith, David J. Maron

October 11, 2015

Presentation TCT 2015

Case Presentation: Pretreatment A Patient With Class II Angina and Anterior Wall Ischemia

Presenter: Kevin J. Beatt, Craig R. Smith, Hemal Gada

October 11, 2015

Presentation TCT 2015

The BEST-CLI Study: Rationale and Update

Presenter: J. A. Mustapha, Craig M. Walker, Ehrin J. Armstrong

October 11, 2015

Presentation TCT 2015

Perfusion Assessment in Critical Limb Ischemia in 2015

Presenter: J. A. Mustapha, Craig M. Walker, Mehdi H. Shishehbor

October 11, 2015

Presentation TCT 2015

The Team Approach to Critical Limb Ischemia: Who, How, and Why?

Presenter: J. A. Mustapha, Craig M. Walker, Alex Powell

October 11, 2015

Presentation TCT 2015

From COURAGE and BARI 2D to ISCHEMIA: What Answers Can We Expect (and Not Expect) From ISCHEMIA?

Presenter: Ori Ben-Yehuda, Ajay J. Kirtane, Sripal Bangalore

October 11, 2015

Presentation TCT 2015

Introduction: Why Is This Issue Important? Ischemia vs Bleeding

Presenter: Regina Deible, Roxana Mehran

October 11, 2015

Advertisement

Debate: Are We Really Ready for Phase III Trials? For Limb Ischemia There Are Knowns and Unknowns!

In Patients With End-stage Coronary Artery Disease With Ischemia and Scar, Which Cell Type Will Work Best? No Cell Works. Genes are the Answer.

In Patients With End-stage Coronary Artery Disease With Ischemia and Scar, Which Cell Type Will Work Best? Cardiac Progenitor Cells Are the Only One!

In Patients With End-stage Coronary Artery Disease With Ischemia and Scar, Which Cell Type Will Work Best? Combination of Cells for Additive Effects: This Is the Key!

In Patients With End-stage Coronary Artery Disease With Ischemia and Scar, Which Cell Type Will Work Best? Cardiopoietic Commitment Is the Key!

Coronary CT Imaging: Ischemia vs Anatomy

Case Introduction: A Complex Diabetic Patient With Heart Failure, Ischemia, and Mitral Regurgitation

Stable CAD With Substantial Ischemia and No-to-Mild Symptoms: Initial Revascularization vs Medical Therapy

Advanced CLI BTK Intervention: Two Cases From a Master Level Operator

Approaching the Critical Limb Ischemia Endovascular Procedure: Planning Access, Tools, and Goals

To Angiosome or Not to Angiosome? That Is the Question

Debate: Should Most Patients With Stable Ischemic Heart Disease, Moderate or Greater Ischemia, and Controllable Symptoms Undergo Revascularization? Yes, an Evidence-Based Position!

What the Device Approval Trials Will Tell Us About the Endovascular Approach to CLI and What They Wont

Debate: Should Most Patients With Stable Ischemic Heart Disease, Moderate or Greater Ischemia, and Controllable Symptoms Undergo Revascularization? The Data Says Not as a First-Line Therapy!

Case Presentation: Pretreatment A Patient With Class II Angina and Anterior Wall Ischemia

The BEST-CLI Study: Rationale and Update

Perfusion Assessment in Critical Limb Ischemia in 2015

The Team Approach to Critical Limb Ischemia: Who, How, and Why?

From COURAGE and BARI 2D to ISCHEMIA: What Answers Can We Expect (and Not Expect) From ISCHEMIA?

Introduction: Why Is This Issue Important? Ischemia vs Bleeding

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content